Upgrade to SI Premium - Free Trial

Medicinova (MNOV)

1.81 +0.07 (4.02%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/12/26)

Latest Headlines

MediciNova to Participate in Two Investor Conferences in September September 8, 2026 6:00 AM - StreetInsider Form 8-K MEDICINOVA INC For: Aug 17 August 19, 2026 7:30 AM - SEC Filing Form 10-Q MEDICINOVA INC For: Jun 30 August 13, 2026 4:31 PM - SEC Filing MediciNova reaches 200-patient enrollment in NIH-funded ALS study July 15, 2026 8:03 AM - StreetInsider MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patients July 15, 2026 8:00 AM - StreetInsider MediciNova completes last patient visit in NAFLD Phase 2 trial June 30, 2026 8:01 AM - StreetInsider MediciNova CEO Provides Shareholder Update June 30, 2026 8:00 AM - StreetInsider Form 4 MEDICINOVA INC For: Jun 23 Filed by: Nagao Hideki June 25, 2026 4:38 PM - SEC Filing Form 4 MEDICINOVA INC For: Jun 23 Filed by: Lemerond Nicole June 25, 2026 4:35 PM - SEC Filing Form 4 MEDICINOVA INC For: Jun 23 Filed by: BEAVER CAROLYN June 25, 2026 4:35 PM - SEC Filing Form 8-K MEDICINOVA INC For: Jun 23 June 24, 2026 4:39 PM - SEC Filing Full Article List